SCHEMBL5069997

SCHEMBL5069997

O=C(O)c1ccccc1S(=O)(=O)N1CCCC1

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.65
CYP3A4 P08684 1/20 0.65
CYP2C9 P11712 1/20 0.65
CYP2C19 P33261 1/20 0.65
MCL1 Q07820 1/20 0.61
MEN1 O00255 5/20 0.57
KMT2A Q03164 5/20 0.57
ALDH1A1 P00352 1/20 0.56
LMNA P02545 1/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
TDP1 Q9NUW8 2/20 0.56
FABP3 P05413 1/20 0.55
FABP4 P15090 1/20 0.55
FABP5 Q01469 1/20 0.55
TP53 P04637 1/20 0.52
HSD17B10 Q99714 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17911197 0.87 FABP4 (0.53) TSHRCYP3A4CYP2C9CYP2C19MCL1
SCHEMBL1990490 0.85 ALDH1A1 (0.61) MEN1KMT2AALDH1A1SMN1; SMN2TDP1
SCHEMBL28285074 0.85 POLB (0.58) TSHRCYP2C19KMT2AALDH1A1LMNA
SCHEMBL31565676 0.85 TSHR (0.62) TSHRCYP3A4CYP2C9CYP2C19MCL1
SCHEMBL28285065 0.84 KMT2A (0.55) TSHRCYP3A4CYP2C9CYP2C19MCL1
SCHEMBL15848161 0.83 TSHR (0.66) TSHRCYP3A4CYP2C9CYP2C19MCL1
SCHEMBL11175542 0.83 MEN1 (0.57) TSHRCYP3A4CYP2C9CYP2C19MCL1
SCHEMBL11170665 0.83 MEN1 (0.57) TSHRCYP3A4CYP2C9CYP2C19MCL1
SCHEMBL11181485 0.83 MEN1 (0.57) TSHRCYP3A4CYP2C9CYP2C19MCL1
SCHEMBL11172378 0.83 MEN1 (0.57) TSHRCYP3A4CYP2C9CYP2C19MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3551633-A1 SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS Leo Pharma A/S (DK) 2019-10-16 EP claimed
EP-3551634-A1 SUBSTITUTED PYRAZOLOAZEPIN-8-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS Leo Pharma A/S (DK) 2019-10-16 EP claimed
WO-2018108230-A1 SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS LEO PHARMA A/S (DK) 2018-06-21 WO claimed
WO-2018108231-A1 SUBSTITUTED PYRAZOLOAZEPIN-8-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS LEO PHARMA A/S (DK) 2018-06-21 WO claimed
EP-3551634-A1 SUBSTITUTED PYRAZOLOAZEPIN-8-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS Leo Pharma A/S (DK) 2019-10-16 EP disclosed
EP-3551633-A1 SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS Leo Pharma A/S (DK) 2019-10-16 EP disclosed
WO-2018108230-A1 SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS LEO PHARMA A/S (DK) 2018-06-21 WO disclosed
WO-2018108231-A1 SUBSTITUTED PYRAZOLOAZEPIN-8-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS LEO PHARMA A/S (DK) 2018-06-21 WO disclosed
EP-1934217-A1 NEW COMPOUNDS II Astra Zeneca AB (SE) 2008-06-25 EP disclosed
WO-2007040439-A1 NEW COMPOUNDS II ASTRAZENECA AB (SE) 2007-04-12 WO disclosed
EP-0850218-A1 HERBICIDAL SULFONAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1998-07-01 EP disclosed